Novo Nordisk CEO Warns of Deaths Linked to Compounded Semaglutide
By Robin Foster HealthDay Reporter
THURSDAY, Nov. 7, 2024 (HealthDay News) -- The head of the company that makes the diabetes and obesity drugs Ozempic...
Expanding Access to Obesity Medications Could Avert 42,000 Deaths/Year
Impact of expanding access to GLP-1 receptor agonists, dual gastric inhibitory polypeptide and GLP-1 receptor agonists quantified
FDA Proposes Ban on a ‘Useless’ Decongestant, Phenylephrine
By Ernie Mundell HealthDay Reporter
THURSDAY, Nov. 7, 2024 (HealthDay News) -- More than a year after its advisory panel unanimously declared the drug phenylephrine...
Abortion Rights Measures Pass in 7 States, Fail in 3
By Robin Foster HealthDay Reporter
WEDNESDAY, Nov. 6, 2024 (HealthDay News) -- In election results that showed protecting women's reproductive freedoms matter to a majority...
Medication Abortion Before Confirmed Intrauterine Pregnancy Noninferior
Medication abortion before confirmed intrauterine pregnancy is noninferior to standard, delayed treatment for complete abortion
Smoking Cessation Aids Survival Even Following a Cancer Diagnosis
Maximal survival benefit seen for smoking cessation treatment within six months of diagnosis
Guidance Issued for Safe Use of GLP-1 RAs in the Perioperative Period
GLP-1 receptor agonist use in the perioperative period should be based on shared decision-making of patient and care teams
Recreational Cannabis Legalization Tied to Higher Prenatal Use
Increase driven by individuals living in jurisdictions that permitted adult-use retailers
Medicaid Covers GLP-1 Meds for Obesity in Just 13 States
By Dennis Thompson HealthDay Reporter
TUESDAY, Nov. 5, 2024 (HealthDay News) -- Low-income patients' access to blockbuster weight-loss drugs through Medicaid remains limited, a new...
Multiple Penicillin Courses Linked to Modestly Lower Risk for Parkinson Disease
Increase in PD risk seen in association with exposure to two or more courses of antifungals one to five years prior
